Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Stocks Finish Wild Week with a Whimper
4 Speculative Biotech Stocks To Consider
A Candid Conversation With Athersys CEO Gil Van Bokkelen
Athersys: A Significantly Undervalued Stem Cell Company Approaching Key Catalysts
5 Biotech Stocks Under $10 Moving Higher
Stem Cell Therapy Companies: Underappreciated Outperformers
Small-Pharma Watch List: Week Of January 28th
Not really into Drugs? Well, it might be Time!
Top Three Regenerative Medicine Companies Targeting Ischemic Conditions (NAS:ATHX)
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
Athersys: Short Term Catalyst With Long Term Potential